Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Verteporfin PDT + Ranibizumab vs Ranibizumab Monotherapy in AMD
NCT00436553Phase 3Completed
- Sponsor
- Novartis
- Start
- Feb 2007
- Primary completion
- Oct 2009
- Modality
- Light/Condition-Responsive Prodrugs
- Countries
- 2
01
Overview
A Phase 3 trial of verteporfin in age-related macular degeneration (AMD), sponsored by Novartis. Started Feb 2007; status: completed.
02
Drugs
verteporfin
03
Conditions
age-related macular degeneration (AMD)
Beyond the preview
Go deeper on NCT00436553.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00436553.